BioSpace News Archive

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced second quarter 2023 financial results.

Masimo Corporation announced its financial results for the second quarter of 2023, ended July 1, 2023.

QuidelOrtho Corporation, a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced financial results for the second quarter ended July 2, 2023.

Genomma Lab Internacional, S.A.B. de C.V., one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, announced that on August 04, 2023 it has voluntarily prepaid the total amortization for the second tranche of its IFC secured loan.

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that its board of directors has decided to make an equity investment in Novavax, a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, securing 6.5 million shares of common stock through a private placement.

GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, announced that, effective as of August 8, 2023, the compensation committee of GeneDx’s board of directors granted newly-hired employees 23,769 restricted stock units as inducements material to each employee entering into employment with GeneDx.

Benitec Biopharma Inc. announced the pricing of its underwritten public offering of 15,544,041 shares of its common stock and accompanying warrants to purchase up to 15,544,041 shares of common stock.

Belite Bio, Inc (NASDAQ: BLTE) (“Belite” or the “Company”) today announced its financial results for the three months ended June 30, 2023 and provided a general business update.

Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported financial results for the second quarter ended June 30, 2023 and provided a corporate update.

Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the second quarter ended June 30, 2023, and provided business highlights.